Summary
- Current Price
- As of today, VTRS price is $16.28, down -0.91% on
- Current Price All-Time High
- VTRS price is currently -78.77% below its historical high of $76.69 set on
- Market Cap
- VTRS current market cap is $19B, up +65.37% over the past 365 days
- Revenue
- VTRS current annual revenue is $14.29B, down -2.83% year-over-year
- Next Earnings
- The next earnings release for VTRS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Viatris Inc. |
| Ticker | NASDAQ: VTRS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | |
| Website | viatris.com |
| Employees | 32,000 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $16.28 | |
| Price, 1D Change | -0.91% | |
| Market Cap | $19B | |
| TTM Dividend Yield | 2.95% | |
| PE Ratio | - | |
| Beta | 0.69 | |
| Revenue | $14.29B | |
| Revenue, 1Y Change | -2.83% | |
| EPS | -$3.00 | |
| EPS, 1Y Change | -464.89% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.12 | |
| Next Ex-Dividend | $0.12 | |
| Last Split | 3:2 | |
| Next Split | N/A | N/A |
| Last Ticker Change | VTRSV | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | -$3.00 | |
| EPS Estimate | $2.47 | N/A |
| EPS Est. Change | +182.17% | N/A |
| Revenue | $14.29B | |
| Revenue Estimate | $14.78B | N/A |
| Revenue Est. Change | +3.43% | N/A |
| Current Price | $16.28 | |
| Price Target | $19.00 | - |
| Price Tgt. Change | +16.71% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.68 | -$0.53 | -119.82% | |
| $2.31 | -$3.00 | -229.96% | |
| $2.47 | N/A | +182.17% | |
| $2.64 | N/A | +188.00% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $14.82B | $14.71B | -0.73% | |
| $14.12B | $14.29B | +1.21% | |
| $14.78B | N/A | +3.43% | |
| $15.06B | N/A | +5.35% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +67.84% | |
| Price, 3Y | +45.88% | |
| Market Cap, 1Y | +65.37% | |
| Market Cap, 3Y | +37.30% | |
| Revenue, 1Y | -2.83% | |
| Revenue, 3Y | -11.63% | |
| EPS, 1Y | -464.89% | |
| EPS, 3Y | -275.85% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $16.28 | |
| SMA 200 | $14.15 | |
| SMA 50 | $16.55 | |
| EMA 200 | $14.51 | |
| EMA 50 | $16.63 | |
| MACD | $0.07 | |
| Beta | 0.69 | |
| ATR | $0.57 | |
| 14-Day RSI | 40.32 | |
| 10-Day Volatility | 40.48% |
Dividends
| Metric | Value | Date |
|---|---|---|
| Last Paid | $0.12 | |
| Upcoming | $0.12 | |
| Dividend Yield | 2.95% | |
| Total Dividend | $0.48 | |
| $561.20M | ||
| -15.97% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $14.29B | |
| EPS | -$3.00 | |
| Gross Profit | $5.08B | |
| Gross Margin | 35.53% | |
| Operating Income | $423.50M | |
| Operating Margin | 2.96% | |
| Net Income | -$3.51B | |
| Net Margin | -24.58% | |
| EBITDA | $3.22B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 0.98 | |
| 1.38 | ||
| 0.82 | ||
| - | ||
| 7 | ||
| 0.99 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | - | |
| 1.27 | ||
| 1.31 | ||
| 7.30 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $14.71B | |
| $1.45B | ||
| $37.19B | ||
| $9.79B | ||
| $22.48B | ||
| $7.09B | ||
| Total Debt | $14.41B | |
| $1.93B | ||
| $1.29B |
Expenses
| Metric | Value | Date |
|---|---|---|
| $17.81B | ||
| $4.66B | ||
| $9.22B | ||
| $0.00 | ||
| $2.72B | ||
| $0.00 | ||
| -$150.10M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| $2.32B | ||
| -$427.70M | ||
| -$1.29B | ||
| Capex | $465.10M | |
| $1.85B |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Barclays | → | |
| Truist Securities | → | |
| JP Morgan | → | |
| Barclays | → | |
| Piper Sandler | → | |
| Argus Research | → | |
| Barclays | ||
| Truist Securities | ||
| Goldman Sachs | ||
| Jefferies | → |
Analyst sentiment
Institutional ownership
Screeners with VTRS
FAQ
- What is the ticker symbol for Viatris Inc.?
- The ticker symbol for Viatris Inc. is NASDAQ:VTRS
- Does Viatris Inc. pay dividends?
- Yes, Viatris Inc. pays dividends. The last payment was $0.12, with an ex-dividend date on May 22, 2026
- What sector is Viatris Inc. in?
- Viatris Inc. is in the Healthcare sector
- What industry is Viatris Inc. in?
- Viatris Inc. is in the Specialty & Generic Drug Manufacturers industry
- What country is Viatris Inc. based in?
- Viatris Inc. is headquartered in United States
- When did Viatris Inc. go public?
- Viatris Inc. initial public offering (IPO) was on March 17, 1980
- Is Viatris Inc. in the S&P 500?
- Yes, Viatris Inc. is included in the S&P 500 index
- Is Viatris Inc. in the NASDAQ 100?
- No, Viatris Inc. is not included in the NASDAQ 100 index
- Is Viatris Inc. in the Dow Jones?
- No, Viatris Inc. is not included in the Dow Jones index
- When was Viatris Inc. last earnings report?
- Viatris Inc.'s most recent earnings report was on August 6, 2026
- When does Viatris Inc. report earnings?
- The next expected earnings date for Viatris Inc. is November 5, 2026
Data Sources & References
- VTRS Official Website www.viatris.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1792044/000179204426000013/0001792044-26-000013-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- VTRS Profile on Yahoo Finance finance.yahoo.com/quote/VTRS
- VTRS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vtrs